2-Chloro-5-methyl-3-nitropyridine, 98.0%, 100g

5,5'-Diiodo-2,2'-bithiophene, 98%, 5g

BSTFA-TMCS (99:1) [Derivatizing Reagent for GC]100mL

2,2,3,4,4,4-Hexafluorobutyl methacrylate, 98.0%, 100g

BIS(3-(HYDROXYMETHYL)AZETIDIN-3-OL); OXALIC ACID, 95.0%, 500mg

Oxetane-3,3-diyldimethanol, 95.0%, 100g

Methyl 3-chloro-5-(N-(4,6-difluoro-[1,1'-biphenyl]-3-yl)sulfamoyl)-4-hydroxybenzoate, 98.0%, 10mg

(5-Chloropyridin-3-yl)boronic acid, 95.0%, 1g

GSK-3787, 95.0%, 50mg

3-Amino-6-methoxy-5-methyl-pyridine, 95.0%, 5g

(4-Vinylphenyl)methanol, 95.0%, 10g

3-Fluoro-2,2-dimethylpropanoic acid, 95.0%, 100mg

3-(methylthio)-1-(3-(thiophen-2-yl)-1,2,4-oxadiazol-5-yl)propan-1-amine oxalate, 95.0%, 1g